NCT01709708View on ClinicalTrials.gov

Use of the Tx360 Nasal Applicator in the Treatment of Chronic Migraine

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Chronic Migraine
Interventions
DRUG

Marcaine

Marcaine used as a topical local anesthetic to block the SPG by delivering Marcaine directly to the specific area of mucosa associated with the SPG.

DRUG

Saline

Saline

Trial Locations (2)

48104

Michigan Head Pain & Neurological Institute, Ann Arbor

65807

Clinvest/A Division of Banyan Group, Inc., Springfield

All Listed Sponsors
collaborator

Clinvest

OTHER

lead

Tian Medical Inc.

INDUSTRY

NCT01709708 - Use of the Tx360 Nasal Applicator in the Treatment of Chronic Migraine | Biotech Hunter | Biotech Hunter